BEVERLY, MA and TORONTO, Ontario – June 13, 2011 - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of advanced laser systems for the regenerative medicine, fertility and stem cell research markets, today announced the advancement of the collaboration with ISee3D Inc. to market their unique single camera, single lens, single chip 3D microscope technology currently under development.

The technology partnership was formed to develop a single lens 3D microscope adapter that will result in the support of 3D display by research grade microscopes currently only capable of 2D. Under this agreement, Hamilton Thorne has exclusive rights to sell the ISee3D three-dimensional technology with its lasers within certain cell research and regenerative medical research markets.The product will support both inverted and upright configurations, and is expected to be released in the fall of 2011.

The 3D lens provides researchers with an innovative way to view cells and easily conduct scientific processes. The adapter produces 3D imaging through the video channel via the camera’s optical port and is optimized for use in biological research. The adapter provides a cost-effective solution for this grade of camera/microscope configuration and may also be fitted with a universal adapter to support other high-powered microscopes.

“Hamilton Thorne is excited to be working with the superb technical team at ISee3D. We believe that the three-dimensional capabilities of ISee3D’s technology applied to microscopy can be a real game changer in cell biology,” said Meg Spencer, Chief Executive Officer of Hamilton Thorne Ltd. “Coupled with our miniature lasers, researchers will have new capabilities in robotic micro surgery and will be able to fully visualize many types of cells, cultures and tissue sections. Further, we feel that ISee3D is well aligned with Hamilton Thorne’s vision and goals for developing ground-breaking solutions in the lab, and our technology synergies could open up new ways for researchers to see the world of cell biology.”

“We believe this single lens 3D adapter will be another great example of expanding the use of 3D in microscopy using ISee3D’s technology. We are privileged to have Hamilton Thorne’s expertise to guide us in the deployment of our single lens 3D for research microscopy,” said Bruce Seidel, Business Development at ISee3D.

About Hamilton Thorne Ltd. (www.hamiltonthorne.com)

Hamilton Thorne provides novel solutions for Life Science that reduce cost, increase productivity as much as ten-fold, and enable research breakthroughs in regenerative medicine, stem cell research and fertility markets. The Company’s new Staccato™ and Stiletto™ laser systems also offer significant scientific advantages in the fields of developmental biology, cancer research and advanced cell biology. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and procedures. Each member of Hamilton Thorne’s family of products serves a different research purpose. By simply turning the microscope turret, researchers can have a new world of scientific capabilities at their fingertips.

Hamilton Thorne’s growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard University, MIT, Yale, McGill University, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, Oxford University, and Cambridge.

About ISee3D

ISee3D is driving the universal adoption of 3D single lens capture – from consumers and Hollywood to health care and military. The company is introducing the first commercially feasible single lens, single camera 3D capture technology. Scalable in size from one mm in diameter to more than 250 mm, the patented technology can be applied across many devices. Through its patented optical switch technologies, ISee3D continues to aggressively pursue the best in 3D innovation to ensure an immersive 3D viewing experience, rather than the traditional two lenses or 2D conversion approaches that are the current standard. The company is headquartered in Vancouver with offices in Toronto.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at www.sedar.com.

Subscribe to Our Investor Email List